Real-time enrollment status for this nash clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:51 PM UTC
| NCT Number | NCT06215716 |
| Recruiting Status | Recruiting |
| Condition | NASH |
| Phase | PHASE3 |
| Target Enrollment | 1,650 participants |
| Active Locations | 203 sites in the US |
| Sponsor | Akero Therapeutics, Inc |
| Last Updated on CT.gov | October 15, 2026 (Yesterday) |
As of October 16, 2026: Clinical trial NCT06215716 is currently recruiting participants. This phase3 study for nash is actively seeking new participants at 203 locations across the United States. The study is sponsored by Akero Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06215716 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 203 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06215716 was last updated Yesterday (October 15, 2026). HelloStudys verifies this status automatically.